Boston Scientific said on Wednesday it will stop pursuing U.S. approval for its experimental heart device due to increased clinical and regulatory requirements.
Original Image Link
Source:www.reuters.com
Original Image Link
Source:www.reuters.com
Posted: 2025-05-28 04:09:00